A novel breath test, measuring the immune response to the H1N1 flu virus, could help to ease future vaccine shortages by identifying the people who have already been infected with the flu virus.
In a study published today, 15 July 2011, in IOP Publishing's Journal of Breath Research, researchers have investigated an easy, non-invasive breath test to measure biomolecules that accumulate in response to the H1N1 strain.
Research published last month claimed that over half of the people in Glasgow vaccinated during the 2009 swine flu pandemic were already infected with the flu virus, meaning they were vaccinated unnecessarily. It is thought that similar patterns would have been found throughout the UK.
These vaccinations would not have harmed the people concerned, however local health authorities would have been affected as they attempted to administer the vaccine quickly and effectively on limited supplies.
A fast-acting, non-invasive test for the virus could therefore help to avoid unnecessary vaccinations and help prioritise the people who most need the vaccines.
The researchers, from Cleveland Clinic and Syft Technologies, enrolled 11 individuals on their study of which nine were given the live attenuated H1N1 vaccine and administered the breath test on each of the following seven days.
The breath test examined exhaled nitric oxide (NO) – a biomolecule whose production has previously been linked to influenza and viral infection and has been speculated to play a beneficial role in viral clearance.
The results showed a peak in NO levels in all subjects on the third day after vaccination. There were no significant differences in NO levels on any other day.
Of the 11 other compounds examined in the study, only one compound – isoprene - showed an elevated level, again on day three. Increased levels of isoprene, a compound produced within the body and a major constituent of exhaled breath, have been reported to reflect oxidative stress in the airways.
Previous findings show that the highest number, and severity, of symptoms related to a H1N1 infection occur on day three, suggesting, along with this research, that this is when an immune response is triggered in the body.
The H1N1 swine flu pandemic of 2009 affected over 214 countries and resulted in approximately 43 million illnesses and 8,870,449 deaths.
This study presents the first direct evidence of a potential test to diagnose H1N1 influenza using your breath, a concept which has already been used to diagnose and monitor asthma, check for transplant organ rejection, and to detect lung cancer and alcohol intoxication.
If a fast, easy, non-invasive breath test is to be mass-produced, the researchers state that further work will need to identify other compounds associated with an immune response that were only touched upon in this study, as well as identifying the exact mechanism underlying the increase in exhaled NO as a result of the live vaccine.
One of the study's authors Professor Raed Dweik said, "This study adds to the growing evidence for the utility of breath analysis in medical diagnostics. More work still needs to be done, however, to identify the specific compounds that change in response to vaccination and to find the biologic link between those compounds and the host response to the vaccine or the actual disease."
From 15 July 2011, this paper can be downloaded from iopscience.org/jbr/5/3/037107
Notes to Editors
Contact
1. For further information, a full draft of the journal paper or contact with one of the researchers, contact IOP Press Assistant, Michael Bishop:
Tel: 0117 930 1032
E-mail: Michael.bishop@iop.org
Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FENO) and other volatiles in exhaled breath
2. The published version of the paper "Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FENO) and other volatiles in exhaled breath" 2011 J. Breath Res. 5 037107 will be freely available online from 15 July 2011. It will be available at iopscience.org/jbr/5/3/037107
Journal of Breath Research
3. This journal is dedicated to all aspects of breath science, with the major focus on analysis of exhaled breath in physiology and medicine, and the diagnosis and treatment of breath odours.
IOP Publishing
4. IOP Publishing provides publications through which leading-edge scientific research is distributed worldwide. IOP Publishing is central to the Institute of Physics (IOP), a not-for-profit society. Any financial surplus earned by IOP Publishing goes to support science through the activities of IOP.Beyond our traditional journals programme, we make high-value scientific information easily accessible through an ever-evolving portfolio of community websites, magazines, conference proceedings and a multitude of electronic services. Focused on making the most of new technologies, we're continually improving our electronic interfaces to make it easier for researchers to find exactly what they need, when they need it, in the format that suits them best. Go to http://publishing.iop.org/.
The Institute of Physics
5. The Institute of Physics is a leading scientific society promoting physics and bringing physicists together for the benefit of all.
It has a worldwide membership of around 40 000 comprising physicists from all sectors, as well as those with an interest in physics. It works to advance physics research, application and education; and engages with policymakers and the public to develop awareness and understanding of physics. Its publishing company, IOP Publishing, is a world leader in professional scientific publishing and the electronic dissemination of physics. Go to www.iop.org
Journal
Journal of Breath Research